Maze Therapeutics Inc Sustainability Reports
Maze Therapeutics Inc. is a clinical-stage biopharmaceutical company that leverages human genetics and variant functionalization to develop novel small-molecule precision medicines. The company focuses primarily on treatments for renal, cardiovascular, and related metabolic diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00NHJHS36
No reports are currently available in our catalogue.